Lutein is a competitive inhibitor of cytosolic Ca2+-dependent phospholipase A2

Journal of Pharmacy and Pharmacology

Volumn 62, Issue 12, 2010, Pages 1711-1716

  Song, Ho Sun ^a   Kim, Hee Rae ^a   Kim, Myung Cheul ^a   Hwang, Yeon Hee ^a   Sim, Sang Soo ^a  

^a Chung Ang University   (South Korea)

Author keywords

Arachidonic acid; Lutein; Phospholipase A2

Indexed keywords

ARACHIDONIC ACID; CALCIUM ION; CARBON 14; DITHIOTHREITOL; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; ISOENZYME; MELITTIN; PHOSPHATIDYLCHOLINE; PHOSPHOLIPASE A2; PYRENE DERIVATIVE; TRITIUM; XANTHOPHYLL;

ANIMAL CELL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; ATHEROSCLEROSIS; CELL CULTURE; COMPETITIVE INHIBITION; CONTROLLED STUDY; CYTOSOL; DOSE TIME EFFECT RELATION; ENZYME ASSAY; ENZYME INHIBITION; ENZYME SUBSTRATE; EYE DISEASE; HYDROLYSIS; INFLAMMATION; ISOTOPE LABELING; MACROPHAGE; MOUSE; NONHUMAN; SKIN DEFECT; ULTRAVIOLET IRRADIATION;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ARACHIDONIC ACID; BLOOD PROTEINS; CALCIUM; CELLS, CULTURED; CYTOSOL; ISOENZYMES; LUTEIN; MICE; PHOSPHATIDYLCHOLINES; PHOSPHOLIPASES A2;

EID: 77954919849     PISSN: 00223573     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.2042-7158.2010.01145.x     Document Type: Article

References (30)

1. 2 enzymes: selective inhibitors and their pharmacological potential. Adv Pharmacol 1995; 32: 31-66.
2. Calunga JL et al. Ozone oxidative post-conditioning in acute renal failure. J Pharm Pharmacol 2009; 61: 221-227.
3. 2 enzymes. Prostaglandins Other Lipid Mediat 2002; 68-69: 3-58.
4. 2. J Biol Chem 1998; 273: 14411-14423.
5. Sommerburg O et al. Fruits and vegetables that are sources for lutein and zeaxanthin: the macular pigment in human eyes. Br J Ophthalmol 1998; 82: 907-910.
6. Granado F et al. Nutritional and clinical relevance of lutein in human health. Br J Nutr 2003; 90: 487-502.
7. Nakajima Y et al. Astaxanthin, a dietary carotenoid, protects retinal cells against oxidative stress in-vitro and in mice in-vivo. J Pharm Pharmacol 2008; 60: 1365-1374.
8. Demmig-Adams B et al. Carotenoids 3: in vivo function of carotenoids in higher plants. FASEB J 1996; 10: 403-412.
9. Landrum JT, Bone RA. Lutein, zeaxanthin, and the macular pigment. Arch Biochem Biophys 2001; 385: 28-40.
10. Mares-Perlman JA et al. Lutein and zeaxanthin in the diet and serum and their relation to age-related maculopathy in the third National Health and Nutrition Examination Survey. Am J Epidemiol 2001; 153: 424-432.
11. Brown L et al. A prospective study of carotenoid intake and risk of cataract extraction in US men. Am J Clin Nutr 1999; 70: 517-524.
12. Dwyer JH et al. Oxygenated carotenoid lutein and progression of early atherosclerosis - The Los Angeles Atherosclerosis Study. Circulation 2001; 103: 2922-2927.
13. Stahl W et al. Carotenoids and carotenoids plus vitamin E protect against ultraviolet light-induced erythema in humans. Am J Clin Nutr 2000; 71: 795-798.
14. 2 in NF-kB activation. Free Radic Biol Med 2008; 45: 885-896.
15. Balboa MA et al. Regulation of arachidonic acid mobilization in lipopolysaccharide-activated P388D(1) macrophages by adenosine triphosphate. J Biol Chem 1999; 274: 36764-36768.
16. 2 on arachidonic acid release induced by reactive oxygen species. Arch Biochem Biophys 2001; 392: 257-262.
17. 2 by bromoenol lactone and trifluoromethyl ketones. J Biol Chem 1995; 270: 445-450.
18. 2 plays a role in arachidonic acid release and eicosanoid biosynthesis by mast cells. J Immunol 1994; 152: 5438-5446.
19. 2, blocks production of arachidonate and 12-hydroxyeicosatetraenoic acid by calcium ionophore-challenged platelets. J Biol Chem 1994; 269: 15619-15624.
20. Dole VP, Meinertz H. Microdetermination of long-chain fatty acids in plasma and tissues. J Biol Chem 1960; 235: 2595-2599.
21. 2 using pyrene-labeled phospholipids in the presence of serum albumin. Anal Biochem 1989; 177: 103-109.
22. 2 with fluorescent phospholipid substrates. Chembiochem 2007; 8: 1555-1569.
23. Lusa S et al. Degradation of pyrene-labelled phospholipids by lysosomal phospholipases in vitro. Dependence of degradation on the length and position of the labelled and unlabelled acyl chains. Biochem J 1996; 315: 947-952.
24. Nielsen OH et al. Arachidonic acid and calcium metabolism in rnelittin stimulated neutrophils. Mediators Inflamm 1992; 1: 313-317.
25. 2 by methyl arachidonyl fluorophosphonate. Biochim Biophys Acta 1996; 1302: 55-60.
26. 2. Annu Rev Pharmacol Toxicol 1999; 39: 175-189.
27. Okulski W et al. Dipalmitoylphosphatidylcholine membranes modified with carotenoid pigment lutein: experiment versus Monte Carlo simulation study of the membrane organization. Biochim Biophys Acta 2008; 1778: 2105-2118.
28. 2. Biochemistry 1993; 32: 5935-5940.
29. 2 inhibit release of free arachidonate in thrombin-stimulated human platelets. J Biol Chem 1994; 269: 15625-15630.
30. Koutek B et al. Inhibitors of arachidonoyl ethanolamide hydrolysis. J Biol Chem 1994; 269: 22937-22940.